Number of subjects vaccinated* | ||||
---|---|---|---|---|
Total | With any event (%) | P value | ||
Age | ||||
≤ 1 | 23 | 17 | (14) | 0.300 |
1–4 | 58 | 49 | (40) | |
5–14 | 60 | 51 | (42) | |
≥ 15 | 8 | 5 | (4) | |
Sex | ||||
Males | 89 | 73 | (56) | 0.767 |
Females | 68 | 57 | (44) | |
High risk condition | ||||
No | 56 | 48 | (37) | 0.472 |
Yes | 101 | 82 | (63) | |
Detail of high risk conditions | ||||
Anaphylactic syndromes | 25 | 24 | (96) | |
Cardiologic diseases | 8 | 6 | (75) | |
Gastroenterologic diseases | 6 | 4 | (67) | |
Immunodeficiencies | 7 | 5 | (71) | |
Neurologic diseases | 13 | 11 | (85) | |
Previous severe meningitis | 13 | 11 | (85) | |
Haematologic diseases | 11 | 8 | (73) | |
Nephrologic diseases | 6 | 3 | (50) | |
Prematurity | 4 | 4 | (100) | |
Earing disorders | 2 | 2 | (100) | |
Others (Genetic, Infectious, Traumatic disorders) | 6 | 4 | (96) |